David I. Watkins

Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia

Todd M. Allen, David H. O’Connor, Peicheng Jing et al. · Nature · 2000 · 680 citations · Full text

Primary Viraemia, Tat-specific Cytotoxic T, Human Retrovirus +6

Broadly Neutralizing Human Anti-HIV Antibody 2G12 Is Effective in Protection against Mucosal SHIV Challenge Even at Low Serum Neutralizing Titers

Ann J. Hessell, Eva G. Rakasz, Pascal Poignard et al. · PLoS Pathogens · 2009 · 490 citations · Full text

Veterinary Vaccine, Neutralizing Antibodies, Immunology +19

Highly potent HIV-specific antibody neutralization in vitro translates into effective protection against mucosal SHIV challenge in vivo

Brian Moldt, Eva G. Rakasz, Niccole Schultz et al. · Proceedings of the National Academy of Sciences · 2012 · 463 citations · Full text

Genomic epidemiology reveals multiple introductions of Zika virus into the United States

Nathan D. Grubaugh, Jason T. Ladner, Moritz U. G. Kraemer et al. · Nature · 2017 · 383 citations · Full text

Vaccination, Virus Epidemiology, Medicine +7

Reversion of CTL escape–variant immunodeficiency viruses in vivo

Thomas C. Friedrich, Elizabeth Dodds, Levi Yant et al. · Nature Medicine · 2004 · 369 citations · Full text

Human Retrovirus, Immunology, Antiviral Response +4